This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
marijuana: Archive
SAFE Banking Act Resurgence Boosts Pot ETFs: A New Era Ahead?
by Sanghamitra Saha
A fresh wave of investment opportunities emerges as the SAFE Banking Act is reintroduced to Congress, promising brighter prospects for marijuana stocks and ETFs.
MJNegative Net Change YOLONegative Net Change CNBSNegative Net Change MSOSNegative Net Change
etfs marijuana
Is Tilray Brands (TLRY) A Buy Ahead of Fiscal Q3 Earnings Announcement?
by Bryan Hayes
Industry headwinds still present a major challenge.
TLRYPositive Net Change
cannabis earnings investing marijuana meme-stocks pot-stocks
Jazz's (JAZZ) Q4 Earnings Miss Estimates, New Drugs Drive Sales
by Zacks Equity Research
Jazz (JAZZ) reports dismal fourth-quarter results as earnings and sales miss expectations. Sleep disorder drug Xywav become the company's largest product by net sales during the quarter.
JAZZNegative Net Change AMRNNegative Net Change AXSMNegative Net Change ALLONegative Net Change
cannabis earnings marijuana medical
ETF Laggards of 2022 That Are Leading This Year
by Sweta Killa
While the rally has been broad based, the laggards of last year, like technology and communication services sectors as well as growth and small-cap stocks, have been outperforming this year.
ARKKNegative Net Change JSMLNegative Net Change XLCNegative Net Change MEMEPositive Net Change WGMINegative Net Change
bitcoin communications etfs marijuana tech-stocks
Top and Flop ETFs of 2022
by Sweta Killa
We have highlighted three ETFs, each from the best and worst-performing zones of 2022.
OIHPositive Net Change TURNegative Net Change BDRYNegative Net Change PFIXPositive Net Change
energy etfs marijuana tech-stocks
Jazz's (JAZZ) Q3 Earnings Beat Estimates, New Drugs Drive Sales
by Zacks Equity Research
Jazz's Q3 earnings and sales beat expectations on strong demand for new drugs and drugs added with the GW Pharmaceuticals acquisition. The company raises the mid-point of its 2022 sales guidance.
GILDNegative Net Change VRTXNegative Net Change JAZZNegative Net Change
marijuana
Is Tilray Brands (TLRY) A 'Buy' After Q1 Earnings Announcement?
by Bryan Hayes
President Biden recently initiated an official review of how marijuana is scheduled under federal law.
TLRYPositive Net Change
earnings investing marijuana retail stock-performance
Cannabis ETFs Trending Up to Start Q4
by Sweta Killa
Cannabis stocks and ETFs gained momentum to start the fourth quarter thanks to President Joe's announcement of a historic marijuana reform.
YOLONegative Net Change CNBSNegative Net Change MSOSNegative Net Change WEEDNegative Net Change
etfs marijuana
Top and Flop ETFs of Nine Months of 2022
by Sweta Killa
We have highlighted the three ETFs each from the best and worst-performing zones of the nine months of 2022.
UNGNegative Net Change BDRYNegative Net Change YOLONegative Net Change KMLMPositive Net Change DAPPNegative Net Change PFIXPositive Net Change
energy etfs marijuana tech-stocks
Innovative Industrial (IIPR) Cheers Investors With Dividend Hike
by Zacks Equity Research
Innovative Industrial's (IIPR) 2.9% sequential dividend hike reflects its business strength and focus on increasing shareholders' wealth.
PLDNegative Net Change EXRNegative Net Change IIPRPositive Net Change
finance marijuana reit